Chiltern Expands in Asia-Pacific

Friday, May 21, 2010 09:05 AM

UK-based contract research organization (CRO)  Chiltern has announced its expansion plans in Asia-Pacific. 

Chiltern has established two new offices and launched operations in Australia and Singapore–with Singapore acting as the hub for its operations in Southeast Asia. This builds further upon Chiltern’s well established operation in India. Chiltern is also establishing operations in China.

Chiltern’s Asia-Pacific operations will be led by Umakanta Sahoo, Executive Director, Asia-Pacific. “Chiltern’s expansion will provide a broad platform from which global pharmaceutical and biotech Sponsors can expand their geographic reach with confidence and enhance patient recruitment in the Asia-Pacific region,” stated Sahoo.

Glenn Kerkhof, Chiltern’s CEO, stated, “Asia-Pacific is one of the foremost emerging markets in our industry. With the current expansion of pharmaceutical R & D needs into the Asia-Pacific region, Chiltern is well positioned to meet the needs this growth entails. We are very pleased to provide our clients with access to this market while extending our focus on the delivery of high quality, responsive and better value services to our customers.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs